Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Glenmark announces price reduction of 27pc for COVID drug FabiFlu

Ruchika Sharma13 July 2020 2:01 PM IST

Glenmark has announced a price reduction of 27% for FabiFlu. The new MRP is INR 75 per tab from the earlier INR 103 per tab.

Biocon Itolizumab gets DCGI nod to treat COVID-19 patients

Ruchika Sharma13 July 2020 1:28 PM IST

Itolizumab will be manufactured and formulated as an intravenous injection at Biocon’s bio-manufacturing facility at Biocon Park, Bengaluru.

COVID-19: ICMR- AIIMS tells States to use Remdesivir, tocilizumab cautiously

Ruchika Sharma13 July 2020 12:45 PM IST

They told the states that the drugs mentioned as 'investigational therapies' should be used with caution due to their potential for serious adverse...

Cadila Pharma launches Hyperacidity drug Esomeprazole under brand name Esiloc in India

Ruchika Sharma13 July 2020 11:38 AM IST

In an endeavor to improve the treatment options available for hyperacidity & drug induced Gastritis, Esiloc™ will be 50% more economical, thus making...

Fosun-backed Gland Pharma files for Rs 6000-7000 crore IPO

Ruchika Sharma13 July 2020 11:30 AM IST

The proposal for sale comprises of 1,93,68,686 equity shares by Fosun Pharma Industrial Pte Ltd, 1,00,47,435 equity shares by Gland Celsus Bio...

Remdesivir reduced risk of death in Covid-19 patients, more studies needed: Gilead

Ruchika Sharma12 July 2020 10:15 AM IST

Gilead said it analyzed data from 312 patients treated in a late-stage study and a separate real-world retrospective cohort of 818 patients with...

Sanofi, Kymera Therapeutics ink Strategic Partnership To Advance Novel Protein Degrader Therapies

Ruchika Sharma12 July 2020 9:45 AM IST

Kymera will receive $150 million in cash upfront and may receive more than $2 billion in potential development, regulatory and sales milestones, as...

Healthcare focused SaaS startup Zealthix raises USD 1.1 million in seed round

Novavax to get USD 1.6 Billion Funding from Operation Warp Speed

Ruchika Sharma12 July 2020 9:15 AM IST

Gaithersburg: Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, has announced...

COVID Battle: Bhaktivedanta Hospital ties up with Malaysia 'Green Zone'

Ruchika Sharma12 July 2020 9:00 AM IST

The hospital has tied up with a town Melaka from Malaysia," it added. Melaka city, which is also known as Malacca, is the capital of the coastal state...

Pfizer, BioNTech COVID-19 vaccine expected to be ready for approval by 2020 end

Ruchika Sharma12 July 2020 9:00 AM IST

If it receives marketing approval, the companies are preparing to make up to 100 million doses by the end of 2020 and another 1.2 billion doses by the...

Pandemic Has Shown Indian Pharma Industry Is An Asset For World: PM Narendra Modi

Ruchika Sharma11 July 2020 3:15 PM IST

"Vaccines made in India are responsible for two-third of the vaccine needs of the world's children. Even today, our companies are actively...

COVID Cure: DCGI approves Itolizumab for restricted emergency use

Ruchika Sharma11 July 2020 2:43 PM IST

It is for the treatment of ‘cytokine’ release syndrome in moderate to severe acute respiratory distress syndrome patients due to COVID-19, they said.

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok